Citigroup Inc
- SEC CIK
- 0000831001
- Latest filing
- Aug 3, 2026
ATXS holding history
Astria Therapeutics, Inc. in every 13F filed by Citigroup Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATXS overviewAll 13F holders of ATXSFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 12
- Since Q1 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −927,342−100.0% | Sold out | Holders |
| Q4 2025 | 927,342 | $12.1M | <0.1% | +895,513+2,813.5% | Added | Holders |
| Q3 2025 | 31,829 | $231.7K | <0.1% | +1,289+4.2% | Added | Holders |
| Q2 2025 | 30,540 | $163.7K | <0.1% | −4,633−13.2% | Reduced | Holders |
| Q1 2025 | 35,173 | $187.8K | <0.1% | −18,824−34.9% | Reduced | Holders |
| Q4 2024 | 53,997 | $482.7K | <0.1% | +19,951+58.6% | Added | Holders |
| Q3 2024 | 34,046 | $374.8K | <0.1% | +14,010+69.9% | Added | Holders |
| Q2 2024 | 20,036 | $182.3K | <0.1% | −138,539−87.4% | Reduced | Holders |
| Q1 2024 | 158,575 | $2.23M | <0.1% | +153,835+3,245.5% | Added | Holders |
| Q4 2023 | 4,740 | $36.4K | <0.1% | +4,727+36,361.5% | Added | Holders |
| Q3 2023 | 13 | $97 | <0.1% | −13,477−99.9% | Reduced | Holders |
| Q2 2023 | 13,490 | $112.4K | <0.1% | +4,717+53.8% | Added | Holders |
| Q1 2023 | 8,773 | $116.7K | <0.1% | +8,773 | New | Holders |